pubmed-article:10102964 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10102964 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:10102964 | lifeskim:mentions | umls-concept:C0850666 | lld:lifeskim |
pubmed-article:10102964 | lifeskim:mentions | umls-concept:C0205174 | lld:lifeskim |
pubmed-article:10102964 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:10102964 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:10102964 | pubmed:dateCreated | 1999-5-7 | lld:pubmed |
pubmed-article:10102964 | pubmed:abstractText | A furazolidone-containing therapeutic regimen for Helicobacter pylori infection has attracted special interest in the face of a rising world-wide metronidazole resistant H. pylori, and the expense of currently used antimicrobial regimens. | lld:pubmed |
pubmed-article:10102964 | pubmed:language | eng | lld:pubmed |
pubmed-article:10102964 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10102964 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10102964 | pubmed:month | Mar | lld:pubmed |
pubmed-article:10102964 | pubmed:issn | 0269-2813 | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:TytgatG NGN | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:LiuW ZWZ | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:WuS MSM | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:XiaoS DSD | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:ShiYY | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:ZhangD ZDZ | lld:pubmed |
pubmed-article:10102964 | pubmed:author | pubmed-author:XuW WWW | lld:pubmed |
pubmed-article:10102964 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10102964 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:10102964 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10102964 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10102964 | pubmed:pagination | 317-22 | lld:pubmed |
pubmed-article:10102964 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:meshHeading | pubmed-meshheading:10102964... | lld:pubmed |
pubmed-article:10102964 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10102964 | pubmed:articleTitle | Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. | lld:pubmed |
pubmed-article:10102964 | pubmed:affiliation | Shanghai Institute of Digestive Disease, Shanghai Second Medical University, Shanghai, China. | lld:pubmed |
pubmed-article:10102964 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10102964 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10102964 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102964 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102964 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102964 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102964 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102964 | lld:pubmed |